Detalhe da pesquisa
1.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
N Engl J Med
; 384(12): 1101-1112, 2021 03 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33761207
2.
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies.
Allergy
; 79(1): 174-183, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37988255
3.
Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type.
Ann Allergy Asthma Immunol
; 132(3): 383-389.e3, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-37949351
4.
Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
Dermatology
; 240(2): 243-253, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38081155
5.
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
J Eur Acad Dermatol Venereol
; 37(10): 2056-2066, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37335885
6.
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial.
J Am Acad Dermatol
; 86(1): 104-112, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34416294
7.
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet
; 396(10246): 255-266, 2020 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-32711801
8.
Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.
Clin Immunol
; 191: 10-20, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29518577
9.
Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis.
Clin Exp Rheumatol
; 35(3): 390-400, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28079500
10.
Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib.
Ann Rheum Dis
; 79(5): 669-671, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32161057
11.
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.
BMC Infect Dis
; 14: 97, 2014 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-24559321
12.
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
Am J Clin Dermatol
; 25(1): 127-138, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37624488
13.
EhSir2c, a Sir2 homolog from the human pathogen Entamoeba histolytica interacts with a DNA repair protein, EhRAD23: Protein-protein interaction, docking and functional study.
J Biomol Struct Dyn
; 41(1): 263-279, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34809531
14.
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
Am J Clin Dermatol
; 24(4): 609-621, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37213005
15.
In silico analysis of a Skp1 protein homolog from the human pathogen E. histolytica.
J Parasit Dis
; 46(4): 998-1010, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36457763
16.
Abrocitinib monotherapy in Investigator's Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life.
J Dermatolog Treat
; 33(5): 2605-2613, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35763326
17.
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial.
Dermatol Ther (Heidelb)
; 12(9): 2077-2085, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35933552
18.
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary.
Immunotherapy
; 14(1): 5-14, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34775830
19.
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
BMC Infect Dis
; 11: 261, 2011 Sep 30.
Artigo
Inglês
| MEDLINE | ID: mdl-21961941
20.
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis.
Crit Care
; 15(5): R253, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22026929